But the picture of weight loss medications for people with eating disorders and disordered eating patterns may be more complex than it seems
Evidence indicates that a meaningful proportion of weight reduction (~25-40%) may involve lean tissue, including skeletal muscle, particularly in the absence of adequate nutritional intake or strength training
The theoretical concerns, chiefly copper accumulation and the thinness of formal AHK-Cu safety study, are flagged as open questions rather than dressed up as risks or waved away
Potential considerations include: Gastrointestinal sensitivity during therapy initiation
Further evidence supporting this hypothesis comes from the typical decrease in bone turnover observed after oral glucose intake, which is inhibited by infusion of octreotide, a somatostatin analog that suppresses the secretion of gastrointestinal and pancreatic peptides [43]
The price can range from $940.95 to $989.45 for a monthly cost